Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Andrea V Barrio"'
Autor:
Sara P. Myers, Varadan Sevilimedu, Andrea V. Barrio, Audree B. Tadros, Anita Mamtani, Mark E. Robson, Monica Morrow, Minna K. Lee
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract BRCA1 and BRCA2 pathogenic variant carriers develop breast cancers with distinct pathological characteristics and mutational signatures that may result in differential response to chemotherapy. We compared rates of pathologic complete respon
Externí odkaz:
https://doaj.org/article/56dd88e241294d48ac3caf9f3c9e9350
Autor:
Adana-Christine Campbell, Kevin G. Kuonqui, Gopika Ashokan, Jonathan Rubin, Jinyeon Shin, Bracha L. Pollack, Arielle Roberts, Ananta Sarker, Hyeung Ju Park, Raghu P. Kataru, Andrea V. Barrio, Babak J. Mehrara
Publikováno v:
Frontiers in Physiology, Vol 15 (2024)
Secondary lymphedema is a common complication following surgical treatment of solid tumors. Although more prevalent in women due to higher breast cancer rates, men also develop lymphedema, often with more severe manifestations. Despite these differen
Externí odkaz:
https://doaj.org/article/584f5ff8e3ea47f8ba129dabb11ddee2
Autor:
Emanuela Ferraro, Jasmeet Singh, Sujata Patil, Pedram Razavi, Shanu Modi, Sarat Chandarlapaty, Andrea V. Barrio, Rachna Malani, Ingo K. Mellinghoff, Adrienne Boire, Hannah Y. Wen, Edi Brogi, Andrew D. Seidman, Larry Norton, Mark E. Robson, Chau T. Dang
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract The addition of pertuzumab (P) to trastuzumab (H) and neoadjuvant chemotherapy (NAC) has decreased the risk of distant recurrence in early stage HER2-positive breast cancer. The incidence of brain metastases (BM) in patients who achieved pat
Externí odkaz:
https://doaj.org/article/5efc975ad4074b27a5124e022f559502
Autor:
Danielle H. Rochlin, MD, Andrea V. Barrio, MD, Sarah A. McLaughlin, MD, Kimberly J. Van Zee, MD, Michelle R. Coriddi, MD, Joseph H. Dayan, MD MBA, Babak J. Mehrara, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 4S, Pp 70-71 (2023)
Externí odkaz:
https://doaj.org/article/6db5bb4fac70482f8f044700f38f531b
Autor:
Andrea V. Barrio, Giacomo Montagna, Varadan Sevilimedu, Ethan Gomez, Dilip Giri, Babak Mehrara, Monica Morrow
Publikováno v:
Cancer Research. 83:P5-08
Background Chronic inflammatory responses initiated by lymphatic injury play a key role in the pathophysiology of secondary lymphedema. However, it is unclear if baseline inflammation or ethnic/racial variability in inflammatory responses increase ly
Autor:
Austin D. Williams, Atif J. Khan, Varadan Sevilimedu, Andrea V. Barrio, Monica Morrow, Anita Mamtani
Publikováno v:
Annals of Surgical Oncology. 29:8037-8043
Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?
Publikováno v:
Annals of Surgical Oncology. 29:8002-8011
Autor:
Giacomo Montagna, Jennifer Zhang, Varadan Sevilimedu, Jillian Charyn, Kelly Abbate, Ethan A. Gomez, Babak Mehrara, Monica Morrow, Andrea V. Barrio
Publikováno v:
JAMA Oncol
IMPORTANCE: Risk factors for breast cancer–related lymphedema (BCRL) after axillary lymph node dissection (ALND) are poorly understood. OBJECTIVE: To evaluate rates of and risk factors associated with BCRL in a prospective cohort of women treated w
Autor:
Tracy-Ann Moo, Jonas A Nelson, Varadan Sevilimedu, Jillian Charyn, Tiana V Le, Robert J Allen, Babak J Mehrara, Andrea V Barrio, Deborah M Capko, Melissa Pilewskie, Alexandra S Heerdt, Audree B Tadros, Mary L Gemignani, Monica Morrow, Virgilio Sacchini
Publikováno v:
British Journal of Surgery.
Background Nipple-sparing mastectomy is associated with a higher risk of mastectomy skin-flap necrosis than conventional skin-sparing mastectomy. There are limited prospective data examining modifiable intraoperative factors that contribute to skin-f
Autor:
Francys C. Verdial, Anita Mamtani, Kate R. Pawloski, Varadan Sevilimedu, Timothy M. D’Alfonso, Hong Zhang, Mary L. Gemignani, Andrea V. Barrio, Monica Morrow, Audree B. Tadros
Publikováno v:
Annals of Surgical Oncology. 29:3810-3819